Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-08 Purchase | 2023-05-10 5:49 pm | Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner | 1,780,000 | $2.8 | $4,984,000 | 10,192,354 (Indirect) | View |
| 2023-05-08 Purchase | 2023-05-10 5:42 pm | Kinnate Biopharma Inc. | KNTE | Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC 10% Owner | 1,780,000 | $2.8 | $4,984,000 | 10,192,354 (Indirect) | View |
| 2023-05-04 Purchase | 2023-05-08 5:22 pm | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,460,932 | $2.797 | $4,086,235 | 1,902,937 (Indirect) | View |
| 2023-05-04 Purchase | 2023-05-08 5:11 pm | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 1,460,932 | $2.797 | $4,086,235 | 1,902,937 (Indirect) | View |
| 2023-04-28 Purchase | 2023-05-02 9:38 pm | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 1,405,168 | $2.6146 | $3,673,901 | 1,328,967 (Indirect) | View |
| 2023-04-28 Purchase | 2023-05-02 9:34 pm | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,405,168 | $2.6146 | $3,673,901 | 1,328,967 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2030-12-02 | Kinnate Biopharma Inc. | KNTE | Tananbaum James B. Director 10% Owner | 13,779,062 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2030-03-23 | Kinnate Biopharma Inc. | KNTE | Farzan Nima CHIEF EXECUTIVE OFFICER | 3,146,241 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2030-08-18 | Kinnate Biopharma Inc. | KNTE | MITCHELL DEAN J Director | 187,003 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2031-06-07 | Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha CHIEF FINANCIAL OFFICER | 734,087 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2030-08-22 | Kinnate Biopharma Inc. | KNTE | Smaldone Alsup Laurie Director | 126,251 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2030-10-23 | Kinnate Biopharma Inc. | KNTE | Epperly Melissa B Director | 126,251 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2028-09-17 | Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director | 231,444 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2030-12-02 | Kinnate Biopharma Inc. | KNTE | Rome Michael E Director | 60,751 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2031-06-24 | Kinnate Biopharma Inc. | KNTE | Sabzevari Helen Director | 85,751 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2033-03-01 | Kinnate Biopharma Inc. | KNTE | DeSimone Jill Director | 50,000 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2030-04-02 | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO GENERAL COUNSEL SECRETARY | 983,589 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:39 pm | N/A 2030-12-02 | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 8,095,480 | $0 | 0 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:33 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 8,009,729 | $0 | 0 (Indirect) | View |
| 2024-04-03 Disposition | 2024-04-05 2:15 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner | 13,718,311 | $0 | 0 (Indirect) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha CHIEF FINANCIAL OFFICER | 1,506 | $2.59 | 64,087 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO GENERAL COUNSEL SECRETARY | 558 | $2.59 | 27,578 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas CHIEF MEDICAL OFFICER | 558 | $2.59 | 67,588 (Direct) | View |
| 2023-12-01 Tax Withholding | 2023-12-05 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas Chief Medical Officer | 541 | $2.25 | 68,146 (Direct) | View |
| 2023-12-01 Tax Withholding | 2023-12-05 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer | 1,459 | $2.25 | 65,593 (Direct) | View |
| 2023-12-01 Tax Withholding | 2023-12-05 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 541 | $2.25 | 28,136 (Direct) | View |
| 2023-09-01 Tax Withholding | 2023-09-06 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer | 1,459 | $2.35 | 67,052 (Direct) | View |
| 2023-09-01 Tax Withholding | 2023-09-06 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 541 | $2.35 | 28,677 (Direct) | View |
| 2023-09-01 Tax Withholding | 2023-09-06 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas Chief Medical Officer | 541 | $2.35 | 68,687 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 6:32 pm | N/A 2033-06-12 | Kinnate Biopharma Inc. | KNTE | Sabzevari Helen Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 6:31 pm | N/A 2033-06-12 | Kinnate Biopharma Inc. | KNTE | Smaldone Alsup Laurie Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 6:30 pm | N/A 2033-06-12 | Kinnate Biopharma Inc. | KNTE | MITCHELL DEAN J Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 6:29 pm | N/A 2033-06-12 | Kinnate Biopharma Inc. | KNTE | GORDON CARL L Director 10% Owner | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 6:28 pm | N/A 2033-06-12 | Kinnate Biopharma Inc. | KNTE | Flaherty Keith T. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 6:26 pm | N/A 2033-06-12 | Kinnate Biopharma Inc. | KNTE | Epperly Melissa B Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-01 Tax Withholding | 2023-06-05 5:01 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas Chief Medical Officer | 541 | $4.3 | 69,228 (Direct) | View |
| 2023-06-01 Tax Withholding | 2023-06-05 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 541 | $4.3 | 29,218 (Direct) | View |
| 2023-06-01 Tax Withholding | 2023-06-05 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer | 1,459 | $4.3 | 68,511 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 5:58 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Williams Richard Thomas Chief Medical Officer | 638 | $5.21 | 67,295 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 5:57 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 638 | $5.21 | 27,286 (Direct) | View |